Beta-catenin is essential for normal bone development.

被引:0
作者
Hilton, MJ [1 ]
Long, F [1 ]
机构
[1] Washington Univ, Sch Med, Dept Internal Med, Div Bone & Mineral Dis, St Louis, MO USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S2 / S2
页数:1
相关论文
共 50 条
[31]   Wnt/beta-catenin signaling plays an essential role in activation of odontogenic mesenchyme during early tooth development [J].
Chen, Jianquan ;
Lan, Yu ;
Baek, Jin-A ;
Gao, Yang ;
Jiang, Rulang .
DEVELOPMENTAL BIOLOGY, 2009, 334 (01) :174-185
[32]   Insulin-like growth factor-I is essential for normal bone development. [J].
Wang, Y ;
Sakata, T ;
Halloran, BP ;
ElAlieh, HZ ;
Munson, SJ ;
Bikle, DD .
JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 :S70-S70
[33]   Cytoplasmic beta-catenin expression correlates with tissue phenotype in both normal and tumor cells and in fibroblastic uveal melanoma cells beta-catenin is present in nuclei. [J].
Kim, K ;
Daniels, KJ ;
Hay, ED .
MOLECULAR BIOLOGY OF THE CELL, 1997, 8 :2495-2495
[34]   In melanoma, beta-catenin is a suppressor of invasion [J].
I Arozarena ;
H Bischof ;
D Gilby ;
B Belloni ;
R Dummer ;
C Wellbrock .
Oncogene, 2011, 30 :4531-4543
[35]   The WNT/beta-catenin pathway in melanoma [J].
Larue, L ;
Delmas, V .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2006, 11 :733-742
[36]   Understanding Wnt/beta-catenin signaling [J].
Xi, H .
FASEB JOURNAL, 2006, 20 (05) :A1337-A1337
[37]   Nuclear beta-catenin in mesenchymal tumors [J].
Ng, TL ;
Gown, AM ;
Barry, TS ;
Cheang, MCU ;
Chan, AKW ;
Turbin, DA ;
Hsu, FD ;
West, RB ;
Nielsen, TO .
MODERN PATHOLOGY, 2005, 18 (01) :68-74
[38]   In melanoma, beta-catenin is a suppressor of invasion [J].
Arozarena, I. ;
Bischof, H. ;
Gilby, D. ;
Belloni, B. ;
Dummer, R. ;
Wellbrock, C. .
ONCOGENE, 2011, 30 (45) :4531-4543
[39]   Isolation and characterization of chicken beta-catenin [J].
Lu, JF ;
Chuong, CM ;
Widelitz, RB .
GENE, 1997, 196 (1-2) :201-207
[40]   MicroRNA roles in beta-catenin pathway [J].
Kai Huang ;
Jun-Xia Zhang ;
Lei Han ;
Yong-Ping You ;
Tao Jiang ;
Pei-Yu Pu ;
Chun-Sheng Kang .
Molecular Cancer, 9